BMAL CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. BMAL Gen Silencer sind erhältlich als BMAL CRISPR/Cas9 Knockout Plasmide und BMAL Double Nickase Plasmide. BMAL CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
BMAL CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
BMAL1 CRISPR/Cas9 KO Plasmid (h) | sc-400808 | h | Gene Knockout | GFP | 2 | ||
BMAL1 HDR Plasmid (h) | sc-400808-HDR | h | Homology Directed Repair | Puromycin | 2 | ||
BMAL1 Double Nickase Plasmid (h) | sc-400808-NIC | h | Gene Knockout | Puromycin | 2 | ||
BMAL1 Double Nickase Plasmid (h2) | sc-400808-NIC-2 | h | Gene Knockout | Puromycin | 2 | ||
BMAL1 CRISPR/Cas9 KO Plasmid (m) | sc-419206 | m | Gene Knockout | GFP | 1 | ||
BMAL1 HDR Plasmid (m) | sc-419206-HDR | m | Homology Directed Repair | Puromycin | 1 | ||
BMAL1 Double Nickase Plasmid (m) | sc-419206-NIC | m | Gene Knockout | Puromycin | 1 | ||
BMAL1 Double Nickase Plasmid (m2) | sc-419206-NIC-2 | m | Gene Knockout | Puromycin | 1 | ||
BMAL2 CRISPR/Cas9 KO Plasmid (h) | sc-416590 | h | Gene Knockout | GFP | 0 | ||
BMAL2 HDR Plasmid (h) | sc-416590-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
BMAL2 Double Nickase Plasmid (h) | sc-416590-NIC | h | Gene Knockout | Puromycin | 0 | ||
BMAL2 Double Nickase Plasmid (h2) | sc-416590-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
BMAL2 CRISPR/Cas9 KO Plasmid (m) | sc-435462 | m | Gene Knockout | GFP | 0 | ||
BMAL2 HDR Plasmid (m) | sc-435462-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
BMAL2 Double Nickase Plasmid (m) | sc-435462-NIC | m | Gene Knockout | Puromycin | 0 | ||
BMAL2 Double Nickase Plasmid (m2) | sc-435462-NIC-2 | m | Gene Knockout | Puromycin | 0 |
BMAL CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
BMAL1 CRISPR Activation Plasmid (h) | sc-400808-ACT | h | Gene Activation | Puro, Blast, Hygro | 2 | ||
BMAL1 CRISPR Activation Plasmid (h2) | sc-400808-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 2 | ||
BMAL1 Lentiviral Activation Particles (h) | sc-400808-LAC | h | Gene Activation | Puro, Blast, Hygro | 2 | ||
BMAL1 Lentiviral Activation Particles (h2) | sc-400808-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 2 | ||
BMAL1 CRISPR Activation Plasmid (m) | sc-419206-ACT | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
BMAL1 CRISPR Activation Plasmid (m2) | sc-419206-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
BMAL1 Lentiviral Activation Particles (m) | sc-419206-LAC | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
BMAL1 Lentiviral Activation Particles (m2) | sc-419206-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
BMAL2 CRISPR Activation Plasmid (h) | sc-416590-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BMAL2 CRISPR Activation Plasmid (h2) | sc-416590-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BMAL2 Lentiviral Activation Particles (h) | sc-416590-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BMAL2 Lentiviral Activation Particles (h2) | sc-416590-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
BMAL2 CRISPR Activation Plasmid (m) | sc-435462-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BMAL2 CRISPR Activation Plasmid (m2) | sc-435462-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BMAL2 Lentiviral Activation Particles (m) | sc-435462-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
BMAL2 Lentiviral Activation Particles (m2) | sc-435462-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |